MPN-386 Real-World Ruxolitinib Treatment Pattern in Myelofibrosis Patients With Thrombocytopenia

Sujan Kabir,Jian Mei,Yifei Wang,Natsumi Ichikawa,Suichi Ino,Claudia Lebedinsky

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览3

暂无评分

摘要

History of thrombocytopenia was a major factor influencing ruxolitinib dose and was associated with history of anemia and neutropenia. Our findings underscore the need for more treatment options to manage myelofibrosis patients with thrombocytopenia.

查看译文

关键词

MPN,myelofibrosis,real-world data,thrombocytopenia

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要